# Antimicrobial Revision in Persistent Febrile Neutropenia

> **NCT05784844** · PHASE4 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT05784844
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was never initiated or activated - Reason was lack of funding
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05784844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05784844, "Antimicrobial Revision in Persistent Febrile Neutropenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05784844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*